Note: This post was crossposted from the Coefficient Giving Farm Animal Welfare Research Newsletter by the Forum team, with the author's permission. The author may not see or respond to comments on this post.
Subtitle: On vegan advocacy, effective altruism, and FIFA
I turn 40 today. Here are some hot takes.
On factory farming
1. Our biggest challenge is salience. If factory farming led the evening news, it wouldn’t last lo...
Impressions from the 21st Annual U.S. Cluster Headache Patient Conference, organized by Clusterbusters.
On the morning of the last day of the conference, E. was hanging out with other “clusterheads” outside the conference hotel when he started having a cluster headache attack. Before he could go back to his hotel room, J. offered E. his DMT v...
TL;DR:
The movement has an evidence problem. To solve it, for each intervention we need to know:
* What types of evidence that intervention needs
* What types of evidence different sources can give us
In this post, we outline a framework for evidencing an intervention through five stages:
...
New anti-malaria treatment clears phase 3 trials.
I just found that there is a new anti-malarial alternative to artemisinin, the most common antimalarial chemical, which has successfully completed Phase 3 trials. Its nickname is GanLum and apparently has quite powerful effects:
This is an important advance because resistance to artemisinin is one of the growing concerns in the fight against malaria.
You may read more in https://www.npr.org/sections/goats-and-soda/2025/11/12/g-s1-97487/malaria-drug-new and https://www.mmv.org/newsroom/news-resources-search/phase-3-trial-next-generation-malaria-treatment-ganaplacide-lumefantrine .
Very interesting! And very hopeful! Thanks for sharing!